These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16224253)

  • 1. B lymphocytes and systemic sclerosis.
    Fujimoto M; Sato S
    Curr Opin Rheumatol; 2005 Nov; 17(6):746-51. PubMed ID: 16224253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
    Yoshizaki A
    J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal B lymphocyte activation and function in systemic sclerosis.
    Yoshizaki A; Sato S
    Ann Dermatol; 2015 Feb; 27(1):1-9. PubMed ID: 25673924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [B cell abnormalities and autoantibody production in systemic sclerosis].
    Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):73-84. PubMed ID: 16651705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
    Saito E; Fujimoto M; Hasegawa M; Komura K; Hamaguchi Y; Kaburagi Y; Nagaoka T; Takehara K; Tedder TF; Sato S
    J Clin Invest; 2002 Jun; 109(11):1453-62. PubMed ID: 12045259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis.
    Odaka M; Hasegawa M; Hamaguchi Y; Ishiura N; Kumada S; Matsushita T; Komura K; Sato S; Takehara K; Fujimoto M
    Clin Exp Immunol; 2010 Feb; 159(2):176-84. PubMed ID: 19919568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
    Tedder TF; Sato S; Poe JC; Fujimoto M
    Keio J Med; 2000 Mar; 49(1):1-13. PubMed ID: 10750375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.
    Yoshizaki A; Iwata Y; Komura K; Ogawa F; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Tedder TF; Sato S
    Am J Pathol; 2008 Jun; 172(6):1650-63. PubMed ID: 18467694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis.
    Hitomi Y; Tsuchiya N; Hasegawa M; Fujimoto M; Takehara K; Tokunaga K; Sato S
    Tissue Antigens; 2007 Mar; 69(3):242-9. PubMed ID: 17493148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
    Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
    Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative genetic variation in CD19 expression correlates with autoimmunity.
    Sato S; Hasegawa M; Fujimoto M; Tedder TF; Takehara K
    J Immunol; 2000 Dec; 165(11):6635-43. PubMed ID: 11086109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.
    Clark EA; Giltiay NV
    Front Immunol; 2018; 9():2235. PubMed ID: 30323814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.